Skip Navigation LinksHome > September 2011 - Volume 45 - Issue 8 > Antibodies Against Deamidated Gliadin Peptides in Early-stag...
Journal of Clinical Gastroenterology:
doi: 10.1097/MCG.0b013e3181fbdfa6
ALIMENTARY TRACT: Original Articles

Antibodies Against Deamidated Gliadin Peptides in Early-stage Celiac Disease

Kurppa, Kalle MD*; Lindfors, Katri PhD*; Collin, Pekka MD, PhD; Saavalainen, Päivi PhD; Partanen, Jukka MD, PhD§; Haimila, Katri PhD§; Huhtala, Heini MSc; Laurila, Kaija MSc*; Mäki, Markku MD, PhD*; Kaukinen, Katri MD, PhD

Collapse Box

Abstract

Background and Goals: The widely used serum endomysial (EmA) and transglutaminase 2 (TG2-ab) antibodies predict forthcoming villous damage and celiac disease when the small-bowel mucosa structure is still normal. However, these autoantibodies may remain negative in this early stage of the disease. We hypothesized that the antibodies against deamidated gliadin peptides (DGP-AGA) might appear before the other antibodies and would thus be useful in the diagnosis and follow-up of patients with early-stage celiac disease.

Study: Serum DGP-AGA, TG2-ab, and EmA were measured at baseline and after 1 year on a gluten-free diet in 42 adults proven to have early-stage celiac disease despite normal small-bowel mucosal morphology (Marsh I-II), and in 20 celiac subjects evincing villous atrophy (Marsh III). Thirty-nine subjects with no signs of celiac disease served as nonceliac controls.

Results: Sensitivity to detect early-stage celiac disease was 79% for DGP-AGA, 64% for TG2-ab, and 81% for EmA. Specificities were 95%, 100%, and 100%, respectively. The corresponding efficiencies of the tests were 89% for DGP-AGA, 81% for TG2-ab, and 91% for EmA. All 3 antibodies were significantly decreased on a gluten-free diet.

Conclusions: This study showed that the sensitivity of DGP-AGA was superior to TG2-ab and comparable to EmA in celiac patients having early-stage celiac disease with normal villous morphology. On the basis of these results, DGP-AGA would seem to offer a promising new method for case-finding and follow-up in this entity.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.